1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y,
et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199–1207.
5. Xiang F, Wang X, He X, Peng Z, Yang B, Zhang J,
et al. Antibody detection and dynamic characteristics in patients with COVID-19. Clin Infect Dis 2020 Apr 19 [Epub].
https://doi.org/10.1093/cid/ciaa461.
7. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020;14:69–71.
11. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007;357:1450–1451.
12. Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW,
et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011;52:447–456.
13. Burnouf T, Radosevich M. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J 2003;9:309.
14. Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH,
et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 2005;24:44–46.
15. Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK,
et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020;26:845–848.
23. Agresti A. Categorical Data Analysis. 3rd ed. Hoboken: John Wiley& Sons, 2013. pp. 12–16.
24. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404–413.
25. Agresti A. An Introduction to Categorical Data Analysis. Hoboken: John Wiley & Sons, 2018. pp. 11–16.
26. Dobson AJ, Barnett AG. An Introduction to Generalized Linear Models. Boca Raton: CRC Press, 2018. pp. 229–238.